Article info

Download PDFPDF

Hospital admission of high risk infants for respiratory syncytial virus infection: implications for palivizumab prophylaxis
  1. Correspondence to:
    Dr Heikkinen
    Department of Paediatrics, Turku University Hospital, FIN-20520 Turku, Finland; terho.heikkinenutu.fi
View Full Text

Citation

Heikkinen T, Valkonen H, Lehtonen L, et al
Hospital admission of high risk infants for respiratory syncytial virus infection: implications for palivizumab prophylaxis

Publication history

  • Accepted October 7, 2003
  • First published December 21, 2004.
Online issue publication 
October 26, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.